CYP26A1 blocking peptide product blog
Tags: Blocking Peptide; CYP26A1; CYP26A1 blocking peptide;
The CYP26A1 cyp26a1 (Catalog #MBS9224800) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The CYP26A1 cyp26a1 product has the following accession number(s) (GI #218511987) (NCBI Accession #O43174.2) (Uniprot Accession #O43174). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Plays a key role in retinoic acid metabolism. Acts on retinoids, including all-trans-retinoic acid (RA) and its stereoisomer 9-cis-RA. Capable of both 4-hydroxylation and 18- hydroxylation. Responsible for generation of several hydroxylated forms of RA, including 4-OH-RA, 4-oxo-RA and 18-OH-RA.
Cellular Location: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein. Tissue Location: Highest levels in adult liver, heart, pituitary gland, adrenal gland, placenta and regions of the brain. The following patways have been known to be associated with this gene. Brain, Embryonic Tissue, Eye, Liver, Lung, Placenta, Testis, Uterus tissues are correlated with this protein. Abnormalities, Multiple, Adenocarcinoma, Breast Neoplasms, Cell Transformation, Neoplastic, Fatty Liver, Hyperplasia, Inflammation, Liver Diseases, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to CYP26A1 Antibody (Center) Blocking Peptide.